Carrión-Marchante, R.; Pinto-DÃez, C.; Klett-Mingo, J.I.; Palacios, E.; Barragán-Usero, M.; Pérez-Morgado, M.I.; Pascual-Mellado, M.; Alcalá, S.; Ruiz-Cañas, L.; Sainz, B., Jr.;
et al. An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment. Pharmaceutics 2023, 15, 1273.
https://doi.org/10.3390/pharmaceutics15041273
AMA Style
Carrión-Marchante R, Pinto-DÃez C, Klett-Mingo JI, Palacios E, Barragán-Usero M, Pérez-Morgado MI, Pascual-Mellado M, Alcalá S, Ruiz-Cañas L, Sainz B Jr.,
et al. An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment. Pharmaceutics. 2023; 15(4):1273.
https://doi.org/10.3390/pharmaceutics15041273
Chicago/Turabian Style
Carrión-Marchante, Rebeca, Celia Pinto-DÃez, José Ignacio Klett-Mingo, Esther Palacios, Miriam Barragán-Usero, M. Isabel Pérez-Morgado, Manuel Pascual-Mellado, Sonia Alcalá, Laura Ruiz-Cañas, Bruno Sainz, Jr.,
and et al. 2023. "An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment" Pharmaceutics 15, no. 4: 1273.
https://doi.org/10.3390/pharmaceutics15041273
APA Style
Carrión-Marchante, R., Pinto-DÃez, C., Klett-Mingo, J. I., Palacios, E., Barragán-Usero, M., Pérez-Morgado, M. I., Pascual-Mellado, M., Alcalá, S., Ruiz-Cañas, L., Sainz, B., Jr., González, V. M., & MartÃn, M. E.
(2023). An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment. Pharmaceutics, 15(4), 1273.
https://doi.org/10.3390/pharmaceutics15041273